Source: ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shan F. Brunel, Janet A. Willment, Gordon D. Brown, Graham Devereux, Adilia Warris. Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity. ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017

Member's Comments

No comment yet.

Related content which might interest you: Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Cytokine production in whole blood and disease severity in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Cytokine-mediated reactive oxygen species hyperproduction in the airway inflammation of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation Source: Eur Respir J 2010; 35: 1264-1272 Year: 2010 The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Arginase in patients with cystic fibrosis airway disease Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 Evaluation of neutrophils phagocytosis and killing in pulmonary cystic fibrosis patients Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 Oxidation contributes to low glutathione in the airways of children with cystic fibrosis Source: Eur Respir J 2014; 44: 122-129 Year: 2014 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis Source: Eur Respir J 2012; 39: 297-304 Year: 2012 CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease Source: Eur Respir J 2015; 46: 395-404 Year: 2015 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002